Research and Markets has announced the addition of the "Canadian Market Report for Orthopedic Hyaluronic Acid 2016 - MedCore" report to their offering.
One of the market limiters for the Canadian HA market is the reimbursement structure. None of the products are covered under standard healthcare plans and must be purchased directly or through extended healthcare coverage or private insurance. Thus, some patients opt out to receiving cortisone injections; these are reimbursed by standard healthcare and are a more affordable choice.
One of the factors that contributed positively to this market is ever expanding indication. The market originally started with treating osteoarthritis (OA) of the knee, since then some products expanded into hip, shoulder, a number of small joints, as well as assisting with post-surgery joint recovery.
As of 2015 the market split between single and three-injection products continues to trend towards single-injection, albeit at a slower pace; single-injection market is currently occupying 57.5% of the total market with the three-injection market accounting for the balance, slightly up from 2012 when single-injection market accounted for 55% share. No device was strictly indicated as a five-injection course only; two brands (Hyalgan® and Ostenil®) are sold as individually packaged syringes and an immaterial number of their units were found to be used as five-injection solutions. For the purpose of this report, all estimated units for these two brands were accounted for under the three-injection category.
Key Topics Covered:
1. Executive Summary
Canadian Orthopedic Biomaterials Market
Top Canadian Orthopedic Biomaterials Companies
2. Research Methodology
3. Orthopedic Hyaluronic Acid Market
3.1 Market Overview
3.2 Market Analysis And Forecast
3.2.1 Single-Injection Ha Market
3.2.2 Three-Injection Ha Market
3.2.3 Five-Injection Ha Market
3.3 Drivers And Limiters
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
For more information about this report visit http://www.researchandmarkets.com/research/3nxhmc/canadian_market
View source version on businesswire.com: http://www.businesswire.com/news/home/20161109005346/en/Business Wire
Last updated on: 09/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.